Last month a client in Shanghai asked me a simple question: “Olivier, should we list our supplements on JD Health or Alibaba Health?” I gave him the honest answer: it depends on who you think is going to buy your pills at 11pm on a Tuesday. That single question tells you almost everything about how China’s online healthcare market actually works in 2026.
I run Gentlemen Marketing Agency here in Shanghai, and health and wellness brands make up a growing share of our client list. Every one of them lands on the same fork in the road: JD Health or Alibaba Health. Both are massive. Both are public companies. Both want your brand’s inventory. But they are not the same animal, and picking the wrong one wastes a year of budget. If you want the broader picture of marketing rules across pharmacy, hospital, and clinic categories in China, we cover that separately in our guide to medical and healthcare marketing in China. This article stays narrow: the platform choice itself.
The Two Giants, One Fight
JD Health (京东健康) and Alibaba Health (阿里健康, often called Ali Health) are the two dominant platforms for online pharmacy, telehealth, and health products in China. Together they cover hundreds of millions of users. Neither is a niche player anymore. Both have insurance partnerships, hospital tie-ins, and their own delivery networks. But they grew out of different parents, and that history still shapes how each one behaves today.
JD Health, built on logistics
JD Health is the healthcare arm of JD.com. That parentage matters more than most people realize. JD built its name on same-day and next-day delivery through its own warehouses, not third-party couriers. JD Health inherited that infrastructure. When a user in Chengdu orders cold medicine at 10pm, there is a real chance it shows up before noon the next day, sometimes in under an hour in big cities through JD’s fast delivery options.
That speed advantage is why JD Health is strong in what I’d call “I need this now” categories: pharmacy orders, chronic disease refills, and health devices people want quickly, like blood pressure monitors or glucose meters. JD’s user base also skews slightly more male and slightly more electronics-and-appliance minded, which carries over into health devices.
Alibaba Health, built on Tmall and Taobao traffic
Alibaba Health grew up next to Tmall and Taobao, and it still leans on that world heavily. A huge share of Ali Health’s pharmacy and supplement business runs through Tmall Health flagship stores, not a separate standalone app experience the way some people assume. If your brand already has a Tmall flagship store for cosmetics or food, adding a health or supplement line under the same roof is a much shorter path with Alibaba Health than starting fresh somewhere else.
Alibaba’s strength is reach and content. Between Taobao livestreaming, KOL partnerships, and the sheer scale of daily active shoppers, Alibaba Health captures a lot of impulse and discovery-driven purchases: vitamins, beauty-from-within supplements, sexual wellness, and general wellness products that people find while browsing rather than searching with intent.
Online Pharmacy: Who Wins the Basket
Both platforms run licensed online pharmacies, and both sell prescription and over-the-counter drugs, subject to China’s rules on what can be sold online and what still requires a physical pharmacy or hospital pickup. The category split looks roughly like this in 2026:
- JD Health tends to win repeat, high-frequency pharmacy orders. Think chronic conditions: diabetes supplies, hypertension medication, thyroid medication. Users come back monthly, and JD’s delivery reliability builds the habit.
- Alibaba Health tends to win first-time and discovery purchases. Think a user who just heard about a supplement from a livestream host and buys on impulse through the Tmall storefront they already trust.
- Both platforms now offer 24 to 48 hour pharmacy delivery in most tier 1 and tier 2 cities, so pure delivery speed is less of a differentiator than it was five years ago. The gap has narrowed, but JD still edges ahead on consistency in smaller cities.
For a foreign OTC brand, this split matters. If your product is something people buy once out of curiosity, a mild sleep aid, a digestive supplement, you likely get more trial volume through Alibaba Health’s Tmall integration. If your product is something people need to reorder every month, JD Health’s retention mechanics work in your favor.
Online Consultation and Prescriptions
Telehealth is where both platforms have invested the most since 2023, and the growth has not slowed down. Chinese consumers, especially younger ones, increasingly prefer a quick video or text consultation over a trip to a crowded hospital for something minor. A cold, a skin rash, a prescription renewal, these are now routinely handled online.
JD Health’s doctor network
JD Health has built one of the largest online doctor networks in the country, with tens of thousands of licensed physicians available for consultation. The flow is straightforward: a user describes symptoms, gets matched with a doctor, and if a prescription is issued, it links directly to JD’s pharmacy for same-platform fulfillment. That closed loop, consultation to prescription to delivery, is JD Health’s core business logic, and it works well for them.
Alibaba Health’s hospital partnerships
Alibaba Health has focused more on partnering with public hospitals to digitize appointment booking, records, and follow-up consultations, alongside its own doctor network. It feels less like a standalone telehealth app and more like an extension of the existing hospital system into your phone. For chronic patients already tied to a specific hospital, that integration can feel more trustworthy than a general online doctor pool.
For a foreign brand, telehealth itself is not usually where you show up directly, unless you are a device or diagnostics company. But it matters indirectly: doctors on both platforms recommend products, and getting your device or supplement into that recommendation flow is a serious long-term play, not a quick win. AI is starting to shape that recommendation flow too. Hospital triage and diagnostic-assist tools have moved past the pilot stage on both platforms, and we go into how that shift is playing out for foreign device and diagnostics companies in our piece on AI in China’s healthcare industry.
Supplements and Health Devices: Where Foreign Brands Actually Play
This is the part most of our clients care about, because most foreign brands entering China through GMA are not pharmaceutical companies. They are supplement brands, OTC brands, and device makers: sleep trackers, posture correctors, air purifiers marketed for health, blood pressure cuffs, and similar products.
Supplements
Supplements sell on story as much as ingredients in China. A vitamin C brand with a clean, credible story and the right KOL push on Alibaba’s world can outperform a technically superior product with no story at all. Ingredient transparency, country of origin, and third-party certification all help build trust, since Chinese consumers have grown more cautious about supplement quality since the scandals of the past decade. Before they ever open JD Health or Tmall, a lot of buyers now search Xiaohongshu first, typing a supplement name or a health complaint straight into the app the way they used to type it into Baidu, and reading the comment section as their trust test. A brand with no organic Xiaohongshu presence is starting the sale one step behind, no matter how good the storefront looks. Cross-border e-commerce channels, which let foreign supplements sell without full domestic registration, run through both JD Health and Tmall Global, so this is not an either-or on the regulatory side. It is more about where your buyers already spend time.
Otto, who runs a small Finnish fish oil and vitamin D supplement brand, learned the discovery-to-reorder split the hard way. He launched on Alibaba Health first, since Tmall Global fit his cross-border setup and a handful of wellness KOLs picked up his omega-3 line during a Nordic-brands livestream push. Sales spiked, then flattened within six weeks because he had no JD Health listing ready for the customers who wanted to reorder monthly without hunting through livestream replays. By the time he got a JD Health storefront live, three months later, a domestic copycat had already grabbed a chunk of the repeat-buyer habit he had paid to create. His fix now is simple: any new SKU launches on both platforms in the same week, even if the JD Health listing starts with a smaller ad budget.
Health devices
Devices behave differently. Buyers research more, compare specs, and read reviews before committing. JD’s user base, more electronics-literate and used to comparing tech specs on JD’s main platform, tends to convert better for devices once you get them to the product page. Alibaba Health can still drive awareness and first exposure through content and livestreaming, even if the actual purchase happens elsewhere. We often recommend brands run visibility campaigns across both, then double down on whichever platform shows the better conversion after the first two or three months of data.
One practical note: device brands that also want visibility beyond these two platforms should not ignore broader online marketing in China, including Baidu SEO, WeChat content, and short video. JD Health and Alibaba Health are sales channels, not your whole marketing plan.
How the Two Platforms Compete for the Same Customer
Here is the part that surprises a lot of foreign executives: JD Health and Alibaba Health are not fighting over different customers most of the time. They are fighting over the same customer at different moments.
- A user discovers a supplement through a Taobao livestream or a Xiaohongshu review (Alibaba Health territory), buys once, likes it, then switches to JD Health for the reorder because delivery is faster and more predictable.
- A user gets a prescription through JD Health’s doctor network, then later buys a related wellness product through a Tmall flagship store because a KOL she follows recommended a specific brand.
- Both platforms now push into insurance integration, letting users pay partially through medical insurance accounts (医保个人账户) in select cities, which locks in loyalty once a user sets that up on one platform.
There is a third channel quietly running underneath both storefronts: WeChat private domain. A lot of the health and supplement brands we work with now pair their JD Health and Tmall listings with a WeChat official account or mini-program where existing buyers get restock reminders, dosage tips, and small loyalty perks directly, without paying platform traffic costs for every repeat order. It does not replace either marketplace, but it gives you a direct line to buyers that neither JD Health nor Alibaba Health will hand you on its own.
The competition is really about who owns the relationship long term: the fast, reliable pharmacy (JD Health) or the trusted, content-rich shopping world (Alibaba Health). Neither has won outright, and I do not expect a clean winner in 2026 or anytime soon after. That is actually good news for foreign brands, because it means you are not locked into one platform for your entire China strategy.
What This Means for Your Brand
I tell clients to stop asking “which platform is bigger” and start asking “which platform matches how my product gets bought.” Here is the short version of how we advise brands at GMA.
If you sell OTC or supplements
Start with Alibaba Health and Tmall Health, especially if you plan to use livestreaming or KOL content to build initial awareness. Once you have repeat buyers, make sure your product is also listed on JD Health so those repeat customers have a fast, reliable reorder path. Running both from day one is fine if your budget allows it, but if you have to choose a starting point, discovery products usually do better starting on Alibaba’s side.
If you sell health devices
Lead with JD Health for the actual sales conversion, since their audience compares specs and trusts JD’s tech-buying reputation. Use Alibaba’s content world, livestreams, short video, KOL reviews, to build the awareness that eventually sends buyers to either platform. Do not expect a device to sell itself just by being listed. Chinese buyers research more for devices than for a bottle of vitamins.
If you are not sure yet
Run a small test on both platforms for 60 to 90 days with a limited SKU set. Track cost per acquisition, repeat purchase rate, and average order value separately for each. The data will tell you more in three months than any amount of planning will tell you in advance. This is standard practice for us at GMA when a new brand enters China without an existing track record on either platform.
Where GMA Fits Into This
Choosing between JD Health and Alibaba Health is a business decision, not just a listing decision. It touches your logistics setup, your content strategy, your KOL budget, and your pricing across cross-border and domestic channels. We help foreign brands work through that decision with actual data instead of guesswork, and we manage the store setup, content, and campaigns once the direction is set.
If you are weighing where to launch your health or wellness product in China, our team can walk you through the platform comparison in detail based on your specific category. Check out our services to see how we support brands through this exact decision.
China’s online healthcare market is not slowing down, and neither is the competition between these two platforms. The brands that win are not the ones that pick the “correct” platform on the first try. They are the ones that test, watch the numbers, and commit budget to whichever channel actually moves their product. That is not a complicated strategy. It just takes discipline, and a willingness to let the data argue with your assumptions.
Frequently Asked Questions
Can a foreign supplement brand sell on both JD Health and Alibaba Health at the same time?
Yes, and for most supplement and OTC brands we work with, running both is the end goal rather than a choice between them. The usual path is to launch discovery-heavy on Alibaba Health and Tmall Global, then open a JD Health storefront once repeat orders start showing up, so you are not sending loyal buyers looking for a monthly refill.
Do I need a Chinese business license to sell on JD Health or Alibaba Health?
Not necessarily. Cross-border e-commerce routes through Tmall Global and JD Worldwide let foreign brands sell many supplement and OTC categories without a domestic entity or full product registration, as long as the product qualifies under China’s CBEC rules. Prescription drugs and some device categories require domestic licensing regardless of the channel.
Which platform is better for a brand’s first year in China?
It depends on the product, not the platform’s overall size. Discovery-driven products like supplements and wellness items usually get more first-year traction on Alibaba Health, while devices and reorder-heavy pharmacy products tend to convert better starting on JD Health. Test both on a small scale before committing a full year’s budget to one.
How important is Xiaohongshu if I am only selling through JD Health or Alibaba Health?
More important than most foreign brands expect. Many Chinese buyers research a supplement or health product on Xiaohongshu before ever opening the marketplace app, checking reviews and KOL posts as a trust check. A weak or absent Xiaohongshu presence quietly drags down conversion on both platforms, even though the sale itself happens elsewhere.
Does WeChat still matter if I already sell on JD Health and Tmall?
Yes, mainly for retention rather than acquisition. A WeChat official account or mini-program lets you talk to buyers who already bought from you, sending restock reminders and usage tips, without paying marketplace traffic costs for every repeat purchase. It works alongside JD Health and Alibaba Health rather than instead of them.
Gentlemen Marketing Agency is a China-focused digital marketing agency based in Shanghai. For health, wellness, and supplement brands specifically, we handle the JD Health and Alibaba Health platform decision, Tmall Global and JD Worldwide store setup, and the KOL, livestreaming, and Xiaohongshu content that drives both first-time trial and repeat orders. Want to know which platform fits your product? Get in touch for a free consultation.
